Psychedelic Outlook 2021: How Far Can This Industry Go?

Industry analysts are bullish about the financial potential of the psychedelic drug market, predicting North American sales of almost $7 billion by 2027. A continuing search for new and effective treatments for burgeoning mental illnesses fuels the confidence. On the other hand, new medicinal drugs can face more regulatory roadblocks than recreational ones. This panel, representing some of the most active companies in psychedelic research and development, will come up with a realistic timetable for the full greenlight for licensed psychoactive healing.

 

Moderator – Katie Pringle

Monday June 20, 6pm - 10pm

Speaker Submissions

If you are in the cannabis growing industry and would like the opportunity to speak at Grow Up Conference and Expo, please click here to apply.